Subscribe: MedWorm: Radiation Therapy
http://www.medworm.com/rss/medicalfeeds/therapies/Radiation-Therapy.xml
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
auntminnie  breast  cancer  medical  new  patients  radiation therapy  radiation  source eurekalert  source  therapy  varian 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Radiation Therapy

MedWorm: Radiation Therapy News



MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Radiation Therapy



Last Build Date: Fri, 16 Feb 2018 02:13:21 +0100

 



Rapid radiation therapy minimizes treatment time, improves quality of life

Thu, 15 Feb 2018 19:58:31 +0100

Faster treatment is possible for a variety of cancers, thanks to hypofractionated radiotherapy currently being employed by doctors at Yale Medicine. (Source: Yale Science and Health News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Only U.S. Cryotherapy Trial for Mesothelioma Finds Success

Wed, 14 Feb 2018 13:48:52 +0100

Thoracic surgeon Dr. Shanda Blackmon at the Mayo Clinic in Rochester, Minnesota, believes there is a place for cryotherapy in the future multidisciplinary treatment of pleural mesothelioma. She wants to show it with this groundbreaking clinical trial. “We think [cryotherapy] could play an important role in treatment,” Blackmon told Asbestos.com. “So far, things look promising, but you can’t say anything specific without more numbers. Right now, it’s a little like telling a story.” Cryotherapy involves destroying cancer cells, or any abnormal tissues, by freezing them with controlled nitrogen vapors. It is often used for external tumors and applied directly with a spraying device. It also is used internally with a tube called a cryoprobe for several types of cancers and precance...



Nivolumab immunotherapy safe, feasible during chemoradiation for adv. head and neck cancer

Tue, 13 Feb 2018 05:00:00 +0100

(American Society for Radiation Oncology) Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers. (Source: EurekAlert! - Medicine and Health)



India clears Varian's Halcyon radiation therapy system

Tue, 06 Feb 2018 17:27:05 +0100

Varian Medical Systems' Halcyon radiation therapy system has received the Atomic...Read more on AuntMinnie.comRelated Reading: Varian acquires Mobius Medical Varian inks deal to acquire Sirtex for $1.3B Varian posts double-digit Q1 gain Varian pursues partnership in China Taiwan clears Varian's radiation therapy system (Source: AuntMinnie.com Headlines)



VCU scientists seek to perfect calculations for comparing cervical cancer radiation doses

Tue, 06 Feb 2018 05:00:00 +0100

(Virginia Commonwealth University) Research from VCU Massey Cancer Center has found that one of the standard practices for comparing cervical cancer radiation therapy treatments may be misleading, and the use of an alternative mathematical formula could be used to more effectively predict and potentially improve outcomes for patients. (Source: EurekAlert! - Medicine and Health)



Adding crizotinib to radiation therapy may help preserve hearing in patients with NF2

Mon, 05 Feb 2018 05:00:00 +0100

(Massachusetts General Hospital) A Massachusetts General Hospital research team reports that the use of crizotinib to block a specific molecular pathway both enhanced the radiosensitivity of tumors in mouse models of NF2, allowing a reduction in radiation dosage, and inhibited the growth of cultured tumor cells from NF2 patients. (Source: EurekAlert! - Cancer)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Why Do Physicians Overtreat Elderly Breast Cancer Patients? Why Do Physicians Overtreat Elderly Breast Cancer Patients?

Thu, 01 Feb 2018 17:00:33 +0100

Drs Kathy Miller and Reshma Jagsi on the reasons behind practitioners'reluctance to omit radiation therapy in older patients.Medscape Oncology (Source: Medscape Radiology Headlines)



PSMA PET/CT visualizes prostate cancer recurrence early, impacts radiation therapy

Thu, 01 Feb 2018 05:00:00 +0100

(Society of Nuclear Medicine and Molecular Imaging) A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The study, which utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11), is documented in the featured article in the February issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)



Varian to Acquire Embattled Sirtex for $1.3B

Thu, 01 Feb 2018 04:20:39 +0100

Varian Medical Systems has revealed plans to acquire interventional oncology specialist Sirtex Medical for $1.3 billion. The proposed acquisition comes about a year after the New South Wales, Australia-based company fired CEO Gilman Wong, following an investigation into his share trading. In January 2017, the Sydney Morning Herald reported Wong was terminated after an investigation revealed he received $2.1 million from the sale of shares in Sirtex about one day after he told investors at the company’s annual general meeting that the company expected “double-digit” dose sales in 2017. Wong was replaced in June 2017 by 20-year industry veteran Andrew McLean. Network with your colleagues in medtech at the MD&M West Conference and Expo, February 6–8, 2018, in Anaheim, CA. Use p...



Elekta inks oncology co-selling deal with IBM Watson Health

Wed, 31 Jan 2018 21:57:13 +0100

Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer care solutions, including the Mosaiq oncology information systems. The combined offerings will be made available in markets including the US, Brazil, India, Australia and select European and Asian markets, Elekta said. “Joining forces with IBM Watson Health positions Elekta as the first radiation therapy company to offer capabilities that combine conventional health information systems with artificial intelligence and cogn...



Microbubbles improve breast cancer radiation therapy

Tue, 30 Jan 2018 19:39:51 +0100

Injecting breast cancer with oxygen-filled microbubbles makes tumors three...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer LED device could predict skin damage from breast RT NEJM: RT boosts heart disease risk in breast cancer patients Robotic IMRT-APBI works well for breast cancer patients SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Varian inks deal to acquire Sirtex for $1.3B

Tue, 30 Jan 2018 19:27:58 +0100

Varian Medical Systems has agreed to acquire interventional oncology therapy...Read more on AuntMinnie.comRelated Reading: Varian posts double-digit Q1 gain Varian pursues partnership in China Taiwan clears Varian's radiation therapy system Sirtex highlights research on colorectal cancer survival Sirtex touts microsphere study at ASCO 2017 NCCN recommends Sirtex's microspheres (Source: AuntMinnie.com Headlines)



MRI scan volume drops in 2017, but new purchases planned

Tue, 30 Jan 2018 18:00:20 +0100

Bucking a consistently upward trend, the total number of MRI procedures in...Read more on AuntMinnie.comRelated Reading: IMV: Imaging sites happiest with mammo systems IMV: Technology drives radiation therapy market IMV: Hospital cardiology moving beyond CPACS, CVIS Report: MRI scanner installed base is long in the tooth Report: CT procedure volume drops 11% over past 2 years (Source: AuntMinnie.com Headlines)



New radiation techniques could improve quality of life for lung cancer patients

Mon, 29 Jan 2018 05:00:00 +0100

(Lawson Health Research Institute) While palliative radiation therapy is used to ease pain in patients with advanced lung cancer, it often has adverse effects on the esophagus which leads to symptoms like heartburn and difficulty swallowing. Through the PROACTIVE clinical trial, Lawson Health Research Institute scientist Dr. Alexander Louie is testing new palliative radiation techniques to spare these effects on the esophagus and improve quality of life for lung cancer patients. (Source: EurekAlert! - Cancer)



Microbubbles make breast cancer more susceptible to radiation therapy

Mon, 29 Jan 2018 05:00:00 +0100

(Thomas Jefferson University) Bursting oxygen-filled microbubbles in breast cancer makes tumors three times more sensitive to radiation therapy in preliminary tests with animal models of the disease (Source: EurekAlert! - Medicine and Health)



Varian posts double-digit Q1 gain

Thu, 25 Jan 2018 07:00:00 +0100

Powered by double-digit growth in its Oncology business segment, Varian Medical...Read more on AuntMinnie.comRelated Reading: Varian pursues partnership in China Taiwan clears Varian's radiation therapy system Varian's Halcyon receives Brazilian market clearance Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil (Source: AuntMinnie.com Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




ASCO Guideline Offers Recommendations for Management of Mesothelioma

Wed, 24 Jan 2018 18:31:37 +0100

ASCO recently released a clinical practice guideline on the treatment of malignant pleural mesothelioma, including recommendations on diagnosis, staging, and treatment with chemotherapy, surgical cytoreduction, and radiation therapy. (Source: CancerNetwork)



Accuray shares rise on FY2018 Q2 EPS beat

Wed, 24 Jan 2018 16:42:37 +0100

Shares in Accuray (NSDQ:ARAY) have risen today after the medical device maker beat expectations on Wall Street with its 2nd quarter earnings results. The Sunnyvale, Calif.-based company posted losses of $4.7 million, or 6¢ per share, on sales of $100.3 million, seeing losses shrink 49.6% while sales grew 14.7% compared with the same period during the prior year. Losses per share were just ahead of the 10¢ consensus on Wall Street. “We have made solid progress towards achieving consistent operating performance during the first half of the fiscal year and we believe we are well on track to achieve our fiscal 2018 guidance, which was originally provided in August. Our 33% year-over-year product revenue growth during the second quarter was primarily driven by solid implementation of o...



ScandiDos brings Delta4 Discover to U.S. market

Wed, 24 Jan 2018 07:00:00 +0100

Swedish radiation therapy quality assurance firm ScandiDos has received the...Read more on AuntMinnie.comRelated Reading: ScandiDos prepares new QA system for ASTRO 2016 FDA clears ScandiDos dosimetry system ScandiDos readies in vivo dosimetry system (Source: AuntMinnie.com Headlines)



In Esophageal Cancer, Lung Radiation Dose Affects Survival In Esophageal Cancer, Lung Radiation Dose Affects Survival

Mon, 22 Jan 2018 17:12:22 +0100

Is decreased survival from radiation therapy to adjacent lung tissue caused by toxicity, or is it due to'unintended consequences'?Medscape Medical News (Source: Medscape Medical News Headlines)



The Road to Meaningful Global Radiotherapy Access The Road to Meaningful Global Radiotherapy Access

Tue, 16 Jan 2018 06:14:37 +0100

About 30 countries in Africa do not have any radiotherapy units. Lack of access to radiation therapy is a sobering reality for patients with cancer in low- and middle-income countries.Journal of Global Oncology (Source: Medscape Today Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




BioProtect wins FDA IDE nod for ProSpace trial

Wed, 10 Jan 2018 19:17:39 +0100

Oncology device developer BioProtect said today it won FDA investigational device exemption approval to launch a pivotal clinical study of its ProSpace balloon system designed to prevent rectal toxicity following prostate cancer radiotherapy. The ProSpace balloon system is a novel balloon spacer designed to temporarily separate the rectum from the prostate during prostate cancer radiation therapy to reduce rectal radiation exposure. The Israel-based company said it plans to launch a prospective, randomized study to explore the safety and effectiveness of the ProSpace spacer to protect the rectum and lower GI tract during radiation therapy for patients with prostate cancer as compared to patients being treated without spacers. “We are addressing a major downside of prostate cancer r...



Varian pursues partnership in China

Tue, 09 Jan 2018 19:46:27 +0100

Varian Medical Systems has signed a memorandum of understanding with healthcare...Read more on AuntMinnie.comRelated Reading: Taiwan clears Varian's radiation therapy system Varian's Halcyon receives Brazilian market clearance Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon (Source: AuntMinnie.com Headlines)



An Update on Radiation Therapy for Brain Metastases An Update on Radiation Therapy for Brain Metastases

Tue, 09 Jan 2018 06:14:37 +0100

Recent advances in radiotherapy for brain metastases are preserving neurocognitive function without compromising survival.Chinese Clinical Oncology (Source: Medscape Today Headlines)



Varian inks Chinese cancer care deal with Ping An, wins Taiwanese nod for Halcyon

Mon, 08 Jan 2018 20:20:42 +0100

Varian Medical (NYSE:VAR) said today it signed a strategic partnership deal with Ping An Health Technology to explore expanding cancer care in China, and that it won Taiwanese approval for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. In its deal with Ping An, Palo Alto, Calif.-based Varian said both companies will explore using artificial intelligence, cloud computing and big data tech to bring high quality, cost-effective cancer care to more individuals in China. “We are pleased to be collaborating with Ping An, the leading force in the field of healthcare in China, on ways to expand the access to high-quality and cost-effective cancer care in China. By leveraging Varian’s advanced technologies and solutions in care managem...



Taiwan clears Varian's radiation therapy system

Mon, 08 Jan 2018 17:29:25 +0100

Varian Medical Systems' Halcyon radiation therapy system has received clearance...Read more on AuntMinnie.comRelated Reading: Varian's Halcyon receives Brazilian market clearance Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon Varian names new chief people officer (Source: AuntMinnie.com Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




One in Five Limited-Stage SCLC Patients Get No Treatment (CME/CE)

Fri, 05 Jan 2018 18:35:03 +0100

(MedPage Today) -- Federally insured patients less likely to get radiation therapy (Source: MedPage Today Radiology)



Radiation therapy algorithm could reduce side effects, maintain effect against tumors

Fri, 05 Jan 2018 05:00:00 +0100

(North Carolina State University) A mathematical model for computing radiation therapy treatments could substantially reduce patient side effects while delivering the same results as conventional radiation therapy. (Source: EurekAlert! - Medicine and Health)



Antioxidant power: Blueberry extract found to improve health outcomes for women receiving radiation for cervical cancer, reducing the damaging effects of the therapy

Thu, 04 Jan 2018 23:08:12 +0100

(Natural News) The extract of blueberry, which is a known superfood, can be beneficial to cervical cancer patients that undergo radiation therapy, according to a study. In the United States, there are about 12,000 women who are diagnosed with cervical cancer. Furthermore, this type of cancer is the fourth most common cancer in women with... (Source: NaturalNews.com)



Medical News Today: How blueberries help to kill cancer cells

Wed, 03 Jan 2018 17:00:00 +0100

Researchers suggest that the success of radiation therapy against cancer cells could be increased significantly, thanks to blueberries. (Source: Health News from Medical News Today)



Berry gives boost to cervical cancer therapy

Fri, 29 Dec 2017 09:00:00 +0100

According to the Centers for Disease Control and Prevention, approximately 12,000 women in the United States are diagnosed with cervical cancer each year. One of the most common treatments for cervical cancer is radiation. While radiation therapy destroys cancer cells, it also destroys nearby healthy cells. University of Missouri School of Medicine researchers studied in vitro human cancer cells to show that combining blueberry extract with radiation can increase the treatment's effectiveness. (Source: World Pharma News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




FDA clears Xcision Medical ’ s GammaPod breast cancer device

Fri, 22 Dec 2017 17:50:22 +0100

The FDA said today that it granted 510(k) clearance to the GammaPod stereotactic radiotherapy device made by Xcision Medical Systems to treat breast cancer. The federal safety watchdog said the GammaPod is designed to treat a portion of the breast in conjunction with breast-conserving surgery. It uses an array of 36 Cobalt-60 sources to beam radiation from within a two-layer vacuum cup that immobilizes the breast to minimize damage to adjacent healthy tissue. GammaPod is not intended to replace whole-breast radiation therapy and has not been shown to be as effective as that technique, the FDA said. The clearance was based on a 17-patient study testing its ability to accurately deliver radiation while minimizing side effects in healthy tissue, such as skin redness or erythema. “With tod...



New measurements to guide radiation therapy

Tue, 19 Dec 2017 05:00:00 +0100

(American Institute of Physics) When ionizing radiation passes through living tissue, it interacts with molecules present in the cells, stripping away electrons and producing charged species known as ions. The electrons produced by this process, known as secondary electrons, can themselves go on to wreak further havoc, causing even more dramatic changes. This week in The Journal of Chemical Physics, investigators report studies of the impact of secondary electrons on a model of DNA. (Source: EurekAlert! - Medicine and Health)



UNC Lineberger awarded $11.9M grant to study radiation treatments for prostate cancer

Mon, 18 Dec 2017 05:00:00 +0100

(UNC Lineberger Comprehensive Cancer Center) The Patient-Centered Outcomes Research Institute has awarded UNC Lineberger Comprehensive Cancer Center's Ronald C. Chen, MD, MPH, a five-year, nearly $12 million grant to fund a comparative study of intensity-modulated radiation therapy and proton beam for prostate cancer. (Source: EurekAlert! - Cancer)



UNC Lineberger awarded $11.9 million grant to study radiation treatments for prostate cancer

Mon, 18 Dec 2017 05:00:00 +0100

(UNC Lineberger Comprehensive Cancer Center) The Patient-Centered Outcomes Research Institute has awarded UNC Lineberger Comprehensive Cancer Center's Ronald C. Chen, MD, MPH, a five-year, nearly $12 million grant to fund a comparative study of intensity-modulated radiation therapy and proton beam for prostate cancer. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




2017 Medtech Company of the Year: Readers & #039; Choice

Sat, 16 Dec 2017 02:11:20 +0100

Each year, MD+DI’s editors gather to choose which company should be named the Medtech Company of the Year, and it’s always a heated debate. This year, we named nine finalists, but the decision to crown Abbott as our 2017 Medtech Company of the Year was unanimous. Our readers, however, had a different opinion. While MD+DI’s editors chose Abbott for its ability to rise above challenges, Bigfoot Biomedical was the favorite among our readership. The Milpitas, CA-based firm is amalgamating other companies’ hardware plus its own software and algorithms to craft an artificial pancreas for patients with diabetes, and readers were impressed by this scrappy startup. “The hopes of millions of diabetics are waiting on them,” one reader wrote. “They have a personal connection which motiva...



Women not getting recommended breast radiation therapy

Fri, 15 Dec 2017 18:56:10 +0100

Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading: ASTRO: Breast radiation 'less scary' than expected JCO releases new sentinel node biopsy guidelines ASTRO: Radiation boost cuts local recurrence in DCIS patients Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)



Oncology Services receives another ISO certification

Wed, 13 Dec 2017 17:44:02 +0100

Radiation therapy service firm Oncology Services International has obtained...Read more on AuntMinnie.comRelated Reading: Oncology Services installs Varian radiotherapy system Consensys teams with rad therapy firm Oncology Services gets ISO recertification Oncology Services International names CEO OSI revenues grew in Q2 (Source: AuntMinnie.com Headlines)



Elekta taps Brainlab as US stereotactic neurosurgery distro partner

Wed, 13 Dec 2017 17:05:45 +0100

Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions. Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance and is commercially available in the US. Stereotactic neurosurgery is a minimally invasive approach to brain surgery designed to treat specific regions of the brain and spare surrounding healthy tissue, and is often used to implant deep brain stimulation leads or to perform lesioning of small brain targets for treating functional disorders. “Early adopters of the Vantage system are experiencing clinical and ...



Combination of Immunotherapy and Radiation Therapy in NSCLC Combination of Immunotherapy and Radiation Therapy in NSCLC

Wed, 13 Dec 2017 06:14:38 +0100

Review the rationale and preclinical evidence for combining radiation and immunotherapy in NSCLC.Translational Lung Cancer Research (Source: Medscape Today Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Glioblastoma survival mechanism reveals new therapeutic target

Mon, 11 Dec 2017 05:00:00 +0100

(Northwestern University) A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation therapy. (Source: EurekAlert! - Cancer)



iCAD touts study on radiation therapy savings

Fri, 08 Dec 2017 07:00:00 +0100

Computer-aided detection developer iCAD is touting a study that found intraoperative...Read more on AuntMinnie.comRelated Reading: iCAD scores Chinese OK for balloon applicators iCAD to highlight Xoft clinical results at AAPM iCAD system treats 1st patient in Australia iCAD to highlight Xoft clinical results at ABS FDA OK's iCAD tomosynthesis software (Source: AuntMinnie.com Headlines)



Varian's Halcyon receives Brazilian market clearance

Wed, 06 Dec 2017 18:27:14 +0100

Varian Medical Systems' Halcyon radiation therapy system has received clearance...Read more on AuntMinnie.comRelated Reading: Oncology Services installs Varian radiotherapy system Varian opens new regional center in Brazil Varian secures Japanese clearance for Halcyon Varian names new chief people officer Varian's fiscal 2017 results hold steady (Source: AuntMinnie.com Headlines)



Distrust In Health-Care System Might Prevent Breast Cancer Patients From Getting Recommended Care

Thu, 30 Nov 2017 19:27:00 +0100

Breast cancer patients who said they didn't trust the health-care system were less likely to get follow-up chemotherapy or hormonal or radiation therapy as recommended by their physician after their initial treatment. (Source: Forbes.com Healthcare News)



Elekta delays rollout for Unity MR-radiation therapy combo

Thu, 30 Nov 2017 13:29:23 +0100

Elekta (STO:EKTA B) today said it’s delaying the rollout of its Unity device, designed to combine magnetic resonance imaging with a linear accelerator for radiation therapy, saying it needs more time to finalize and validate the linac control system. The Swedish company said the decision means it’s postponing its bid for CE Mark approval in the European Union until the first half of next year. “We are convinced that the new technology will revolutionize radiation therapy and create completely new opportunities for physicians and their patients. With the shift in CE Mark and FDA submission, we adjust our target for the first 75 orders accordingly to the first half of calendar year 2020,” CEO Richard Hausmann said in prepared remarks. Elekta also posted fiscal second...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Sharing Mayo Clinic: Throat cancer treatment gives dentist new perspective

Sun, 26 Nov 2017 00:00:00 +0100

After undergoing robotic surgery, radiation therapy and chemotherapy as part of a clinical trial to treat cancer, Bruce Trulson has gained a new understanding of how he can better care for his own patients. In 2015, after nearly 40 years of practicing dentistry, Bruce Trulson, D.D.S., gained new insight into how to care for his [...] (Source: News from Mayo Clinic)



Ludwig researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

Thu, 23 Nov 2017 05:00:00 +0100

(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. (Source: EurekAlert! - Medicine and Health)



Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure Whole Pelvic Radiation, ADT Limit Prostate Cancer Biochemical Failure

Wed, 22 Nov 2017 15:13:04 +0100

Whole pelvic radiation therapy (WPRT) and androgen deprivation therapy (ADT) reduce the risk of biochemical failure in men who receive post-prostatectomy salvage radiotherapy for prostate cancer, according to a database study.Reuters Health Information (Source: Medscape Radiology Headlines)



Children undergoing radiation for cancer may have alternative to sedation

Wed, 15 Nov 2017 05:00:00 +0100

(University of North Texas) Radiation therapy for children with cancer is painless, but preparation for it may cause great stress for a child and his or her family because the child is routinely sedated before each treatment, to stay motionless. Manish Vaidya at the University of North Texas is using a computer program to train young patients to stay motionless so sedation won't be necessary. (Source: EurekAlert! - Cancer)



Jax company starts trial on cancer-fighting therapy

Tue, 14 Nov 2017 13:28:58 +0100

Jacksonville-based TapImmune Inc. (Nasdaq: TPIV) has enrolled its final patient in a randomized, Phase 2 clinical study of an immunotherapy that targets breast cancer. TapImmune's therapies help the body's immune system find and fight cancer, which has evolved to hide from and suppress it, CEO Peter Hoang previously told the Business Journal. This approach is outside of the box of traditional treatment methods like surgery, chemotherapy and radiation therapy tha t shut-down pathways for cancer to… (Source: bizjournals.com Health Care:Physician Practices headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




ViewRay's net loss narrows in Q3

Mon, 13 Nov 2017 17:41:56 +0100

Image-guided radiation therapy developer ViewRay's net loss narrowed in its...Read more on AuntMinnie.comRelated Reading: ViewRay touts pancreatic cancer study results ViewRay raises $50M in stock sale ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM (Source: AuntMinnie.com Headlines)



Androgen Deprivation, Radiation After Prostatectomy Tied to Longer Survival Androgen Deprivation, Radiation After Prostatectomy Tied to Longer Survival

Thu, 09 Nov 2017 22:28:47 +0100

Survival after radical prostatectomy for prostate cancer is better among men who undergo androgen deprivation therapy (ADT) and external beam radiation therapy (EBRT), according to a retrospective analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)



Augmenix touts AMA code, CMS reimbursement for SpaceOar

Tue, 07 Nov 2017 19:38:41 +0100

Augmenix said today that the American Medical Association established a Current Procedural Terminology code for its SpaceOar hydrogel and similar devices, with the Centers for Medicare and Medicaid Services setting a payment rate for procedures with the injectable. The Bedford, Mass.-based company said that the AMA established CPT code 55874 for the periprostatic implantation of biodegradable materials, which SpaceOar will be billed under. The code is set to go into effect January 1, 2018. Augmenix also noted that CMS promulgated their 2018 Medicare Hospital Outpatient Prospective Payment System rule to provide an average reimbursement of $3,706 for outpatient departments and an average of $1,757 for ambulatory service centers that use the AMA code for procedures with the SpaceOar. The ru...



IMV: Imaging sites happiest with mammo systems

Tue, 07 Nov 2017 07:00:00 +0100

Medical imaging facilities are most satisfied with the performance of their...Read more on AuntMinnie.comRelated Reading: IMV: Technology drives radiation therapy market IMV: Hospital cardiology moving beyond CPACS, CVIS Report: MRI scanner installed base is long in the tooth Report: CT procedure volume drops 11% over past 2 years IMV: Cath lab market to grow over next 3 years (Source: AuntMinnie.com Headlines)



Report: Doctor self-diagnoses cancer while testing Butterfly iQ ultrasound

Mon, 30 Oct 2017 14:54:52 +0100

A vascular surgeon was able to diagnose his own cancer while testing the Butterfly Network’s Butterfly iQ ultrasound-on-a-chip device, according to a report from USA Today. After experiencing some throat discomfort Dr. John Martin self-tested the device, designed to send images to and operate in conjunction with Apple (NSDQ:AAPL) iPhones, and found a mass that he thought looked cancerous, according to the report. The mass turned out to be squamous cell cancer which Martin has since received treatment for, including surgery and radiation therapy. “I felt something funny in my neck, connected the probe to my phone, did an ultrasound, and there it was: My tumor,” Martin said, according to USA Today. The Butterfly iQ device won FDA 510(k) clearance earlier this month with 13 cli...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




More early stage lung cancer patients survive the disease

Thu, 26 Oct 2017 04:00:00 +0100

(Elsevier) With the advancement of surgical and radiation therapy strategies for stage 1 non-small-cell lung cancer (NSCLC), more patients are being treated, resulting in higher survival rates, according to a study published online today in The Annals of Thoracic Surgery. (Source: EurekAlert! - Cancer)



ViewRay raises $50M in stock sale

Wed, 25 Oct 2017 16:39:02 +0100

Image-guided radiation therapy developer ViewRay has raised approximately $50...Read more on AuntMinnie.comRelated Reading: ViewRay touts pancreatic cancer study results ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system (Source: AuntMinnie.com Headlines)



ViewRay touts pancreatic cancer study results

Wed, 25 Oct 2017 07:00:00 +0100

Image-guided radiation therapy developer ViewRay is touting study results showing...Read more on AuntMinnie.comRelated Reading: ViewRay launches multicenter trial for pancreatic cancer ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system ViewRay sees drop in Q1 revenue (Source: AuntMinnie.com Headlines)



Proton therapy for prostate cancer is advantageous to imrt according to new study

Wed, 25 Oct 2017 04:00:00 +0100

(Northwestern Memorial HealthCare) Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy (IMRT) according to a new study by researchers at the Northwestern Medicine Chicago Proton Center. (Source: EurekAlert! - Medicine and Health)



Proton therapy may be better option for elderly patients with esophageal cancer

Tue, 24 Oct 2017 04:00:00 +0100

(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




2 Things that Go Together: Yoga and Advanced Lung Cancer 2 Things that Go Together: Yoga and Advanced Lung Cancer

Mon, 23 Oct 2017 23:14:04 +0100

Participating in a yoga program while undergoing radiation therapy improved physical functioning and mental in NSCLC patients, and improved vitality in caregivers.Medscape Medical News (Source: Medscape Medical News Headlines)



Two Things That Go Together: Yoga and Advanced Lung Cancer Two Things That Go Together: Yoga and Advanced Lung Cancer

Mon, 23 Oct 2017 23:04:48 +0100

Participating in a yoga program while undergoing radiation therapy improved physical functioning and mental in NSCLC patients, and improved vitality in caregivers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)



Yoga can be an effective supportive therapy for people with lung cancer and their caregivers

Mon, 23 Oct 2017 04:00:00 +0100

(American Society of Clinical Oncology) In a feasibility trial of people with advanced lung cancer receiving radiation therapy, and their caregivers, yoga was beneficial to both parties. (Source: EurekAlert! - Cancer)



Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

Thu, 19 Oct 2017 04:00:00 +0100

(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian adaptive MR-guided radiation therapy showed a near doubling of median overall survival (27.8 months compared to 14.8 months) and resulted in favorably lower toxicities (0 percent compared to 15.8 percent grade 3 or higher toxicity). (Source: EurekAlert! - Cancer)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Northwestern Medicine Chicago Proton Center hosts 4th Annual PTCOG-NA Conference in Chicago

Thu, 19 Oct 2017 04:00:00 +0100

(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue. (Source: EurekAlert! - Medicine and Health)



Xstrahl lands FDA nod for superficial x-ray therapy

Tue, 17 Oct 2017 16:24:00 +0100

X-ray and radiation therapy technology developer Xstrahl has received U.S....Read more on AuntMinnie.comRelated Reading: Xstrahl sells 20th small-animal system Elekta adds Xstrahl interface Gulmay Medical becomes Xstrahl (Source: AuntMinnie.com Headlines)



CARTI Docs Again Get Highest Nonprofit Salaries

Mon, 16 Oct 2017 05:00:00 +0100

Oncologists from Central Arkansas Radiation Therapy Institute again dominate the list of the state’s highest-paid nonprofit employees, occupying four of the top five positions with total compensation of $1.57 million to $2.3 million in the fiscal year that ended June 30, 2016. (Source: Arkansas Business - Health Care)



In High-Risk Endometrial Cancer, Adding Chemo No Help, but … In High-Risk Endometrial Cancer, Adding Chemo No Help, but …

Mon, 02 Oct 2017 15:12:15 +0100

Vaginal cuff brachytherapy plus chemotherapy was compared to standard radiation therapy alone. The results disappointed, but there is a caveat.Medscape Medical News (Source: Medscape Medical News Headlines)



Elekta and The Alliance for Cancer Care Partner to Bring Leading-edge Radiation Therapy and Radiosurgery Solutions to Patients

Mon, 02 Oct 2017 12:50:52 +0100

The Alliance for Cancer Care converts all oncology treatment devices and software to Elekta products, improving and standardizing care across its multiple sites STOCKHOLM, Oct. 2, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) tod... Elekta, radiation therapy, radiation oncology, radiosurgery (Source: HSMN NewsFeed)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Radiation Therapy for Cancer: Feared, Misunderstood Radiation Therapy for Cancer: Feared, Misunderstood

Fri, 29 Sep 2017 17:10:12 +0100

The word'radiation'triggers scary associations. But a study of breast cancer patients'attitudes about radiation therapy revealed that experience trumps fears. Still, the specialty has a lot of work to do.Medscape Medical News (Source: Medscape Medical News Headlines)



Radiation and Chemotherapy Together Boost Lung Cancer Survival

Wed, 27 Sep 2017 13:00:30 +0100

About one-third of stage 3 patients alive after 5 years, a development called promising by oncologists Source: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Lung Cancer, Radiation Therapy (Source: MedlinePlus Health News)



Hypofractionated RT: Safe and Effective After Mastectomy Hypofractionated RT: Safe and Effective After Mastectomy

Wed, 27 Sep 2017 12:14:08 +0100

Hypofractionated radiation therapy was not inferior to conventional fractionated radiation therapy in the postmastectomy setting, but questions remain.Medscape Medical News (Source: Medscape Today Headlines)



Standard-Dose Radiation Therapy Confirmed in Advanced NSCLC Standard-Dose Radiation Therapy Confirmed in Advanced NSCLC

Wed, 27 Sep 2017 11:12:23 +0100

Mature 5-year follow-up data from the RTOG 0617 trial confirm that a dose of 60 Gy is superior to 74 Gy in advanced inoperable non-small cell lung cancer (NSCLC).Medscape Medical News (Source: Medscape Medical News Headlines)



Treatment That's Easy to Swallow in HPV+ Throat Cancer Treatment That's Easy to Swallow in HPV+ Throat Cancer

Wed, 27 Sep 2017 09:47:49 +0100

The radiation therapy dose for throat cancer was cut 50%, but the 2-year outcomes are still excellent, including no injury to patient swallowing.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Radiation and Chemotherapy Together Boost Lung Cancer Survival

Tue, 26 Sep 2017 19:09:31 +0100

TUESDAY, Sept. 26, 2017 -- Combining radiation therapy with chemotherapy has substantially extended survival for many people with lung cancer, two new studies report. About 32 percent of non-small cell lung cancer patients who received... (Source: Drugs.com - Daily MedNews)



ASTRO: Breast radiation 'less scary' than expected

Tue, 26 Sep 2017 18:33:07 +0100

Breast cancer patients find the experience of radiation therapy to be less...Read more on AuntMinnie.comRelated Reading: ASTRO: Short radiation course safe for breast cancer ASTRO awards $275K to researchers ASTRO honors 43 researchers at annual meeting ACR, ASTRO, AAPM provide guidance updates ASTRO updates insurance coverage policies (Source: AuntMinnie.com Headlines)



High-precision radiotherapy for prostate cancer 'shows promise'

Tue, 26 Sep 2017 17:00:00 +0100

Conclusion This study shows some promising results for targeted pelvic lymph node radiotherapy for men with advanced localised prostate cancer. However, these results can only be treated as preliminary findings for now. This was an early-stage trial that aimed to investigate whether the treatment approach is safe and to get an idea of what doses may be suitable for assessment in further trials. Although it can give an indication of effectiveness, this was not the main aim of the study. Men were not randomised to a treatment group, which means there may have been some differences in the cancers or patient characteristics of men who received the different radiation dosages. This could, in turn, have impacted how effective the treatment was and makes it hard to know at this stage what the opt...



ASTRO: Short radiation course safe for breast cancer

Tue, 26 Sep 2017 07:00:00 +0100

A shorter-course, higher-dose protocol for breast cancer radiation therapy...Read more on AuntMinnie.comRelated Reading: LED device could predict skin damage from breast RT Breast cancer radiation boosts heart disease risk NEJM: RT boosts heart disease risk in breast cancer patients Robotic IMRT-APBI works well for breast cancer patients ASTRO publishes guidelines for accelerated whole-breast RT (Source: AuntMinnie.com Headlines)



Uninsured cancer patients saw increased coverage for care following Medicaid expansion

Tue, 26 Sep 2017 04:00:00 +0100

(American Society for Radiation Oncology) A new study finds that Medicaid expansion enacted as part of the Patient Protection and Affordable Care Act improved coverage for care for cancer patients receiving radiation therapy and potentially decreased health care disparities. (Source: EurekAlert! - Cancer)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Immunotherapy Plus RT for Metastatic Cancer:'Step Forward'Immunotherapy Plus RT for Metastatic Cancer:'Step Forward '

Mon, 25 Sep 2017 19:14:35 +0100

Cancer treatment with radiation therapy typically attempts to achieve local control of tumors with direct hits of radiation therapy. Not this trial.Medscape Medical News (Source: Medscape Medical News Headlines)



ViewRay launches multicenter trial for pancreatic cancer

Mon, 25 Sep 2017 17:32:08 +0100

Image-guided radiation therapy developer ViewRay launched a multicenter prospective...Read more on AuntMinnie.comRelated Reading: ViewRay sees Q2 sales grow, net loss narrows ViewRay to highlight MRIdian Linac research at AAPM 1st patients treated with ViewRay's MRIdian system ViewRay sees drop in Q1 revenue ViewRay boosts borrowing capacity (Source: AuntMinnie.com Headlines)



Breast Cancer Radiation'Less Scary' Than Thought

Mon, 25 Sep 2017 16:00:00 +0100

Majority of patients report more tolerable experience than they expected Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Radiation Therapy (Source: MedlinePlus Health News)



Elekta inks stereotactic development, software, co-marketing deals

Mon, 25 Sep 2017 05:15:01 +0100

Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. Elekta specializes in technological solutions for improving, prolonging and saving the lives of patients with cancer and brain disorders, while IBA develops solutions for the diagnosis and treatment of cancer. Specifically, the companies plan to focus on developing new uses for proton therapy treatment in Elekta’s Monaco treatment planning system and its care management program MOSAIQ Radiation Oncology. “...

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




International trial confirms safety, effectiveness of HDR brachytherapy for cervical cancer

Mon, 25 Sep 2017 04:00:00 +0100

(American Society for Radiation Oncology) Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups. (Source: EurekAlert! - Medicine and Health)



Breast cancer patients largely find radiation therapy experience better than expected

Mon, 25 Sep 2017 04:00:00 +0100

(American Society for Radiation Oncology) A new survey finds breast cancer patients' actual radiation therapy experiences largely exceeded their expectations. (Source: EurekAlert! - Social and Behavioral Science)



Trial confirms pelvic radiation as standard of care for high-risk endometrial cancer

Mon, 25 Sep 2017 04:00:00 +0100

(American Society for Radiation Oncology) In a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy. (Source: EurekAlert! - Cancer)



Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes

Mon, 25 Sep 2017 04:00:00 +0100

(Mayo Clinic) Mayo Clinic researchers have found that a 50 percent reduction in the intensity and dose of radiation therapy for patients with HPV-related throat cancer reduced side effects with no loss in survival and no decrease in cure rates. (Source: EurekAlert! - Cancer)



Halving radiation therapy for HPV-related throat cancer offers fewer side effects and similar outcomes, Mayo study finds

Mon, 25 Sep 2017 00:00:00 +0100

SAN DIEGO ? Mayo Clinic researchers have found that a 50 percent reduction in the intensity and dose of radiation therapy for patients with HPV-related throat cancer reduced side effects with no loss in survival and no decrease in cure rates. Results of a phase II study were presented today at the 59th Annual Meeting [...] (Source: Mayo Clinic Research News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC

Sun, 24 Sep 2017 04:00:00 +0100

(American Society for Radiation Oncology) A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body's immune system to attack the cancer. (Source: EurekAlert! - Cancer)



Adding radiation to chemotherapy may dramatically improve survival for advanced NSCLC

Sun, 24 Sep 2017 04:00:00 +0100

(American Society for Radiation Oncology) Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial reported today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)



Post-mastectomy Radiotherapy Affects Outcomes of Breast Reconstruction Post-mastectomy Radiotherapy Affects Outcomes of Breast Reconstruction

Fri, 22 Sep 2017 20:15:53 +0100

For women who have radiation therapy after mastectomy, autologous reconstruction is associated with a lower risk of complications and better satisfaction with outcome, compared with implant-based breast reconstruction.Reuters Health Information (Source: Medscape Today Headlines)



Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy

Fri, 22 Sep 2017 15:09:11 +0100

Integration of Versa HD linear accelerator and ExacTrac empowers clinicians to optimize radiation therapy inside and outside the brain SAN DIEGO, September 22, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) and Brainlab have recon... Devices, Oncology, Neurosurgery Elekta, Brainlab, Versa HD, ExacTrac, stereotactic, radiosurgery, radiotherapy (Source: HSMN NewsFeed)



New payment models for radiation therapy should consider impact of behavioral health costs Mayo researchers say

Fri, 22 Sep 2017 00:00:00 +0100

SAN DIEGO ? Efforts to develop new payment models in radiation oncology also should consider measures to address behavioral health to reduce the total cost of care during and after radiotherapy, according to the results of study performed by researchers at Mayo Clinic and presented today at the 59th Annual Meeting of the American Society [...] (Source: Mayo Clinic Research News)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.




Varian announces 1st patient treated with Halcyon

Thu, 21 Sep 2017 16:41:59 +0100

Radiation therapy firm Varian Medical Systems announced that a patient with...Read more on AuntMinnie.comRelated Reading: Varian updates treatment planning system Varian holds clinical workshop at Algerian facility Varian appoints new VP Varian inks deal with Bionix Varian treats 1st patient with HyperArc (Source: AuntMinnie.com Headlines)



New clinical trial explores combining immunotherapy and radiation for sarcoma patients

Wed, 20 Sep 2017 04:00:00 +0100

(University of Maryland Medical Center) University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to destroy the main tumor as well as leftover microscopic cancer cells that may seed other tumors. (Source: EurekAlert! - Cancer)



National Cancer Institute designates UCLA brain cancer program a site of research excellence

Wed, 20 Sep 2017 01:27:20 +0100

The brain cancer program at UCLA ’s Jonsson Comprehensive Cancer Center and the UCLA Brain Tumor Center has been designated a Specialized Program of Research Excellence, or SPORE, by the National Cancer Institute, making it one of only five brain cancer programs nationwide to receive this national recognition and substantial rese arch funding.The designation comes with an $11.4 million, five-year grant that recognizes UCLA ’s brain cancer program as one of the best in the country. The program supports research into the prevention, detection and treatment of one of the most lethal and deadly cancers, which often receives far less funding than other types of cancers.The SPORE designation is the second for the Jonsson Cancer Center. In October 2002, the prostate cancer program was named a...



Varian updates treatment planning system

Tue, 19 Sep 2017 07:00:00 +0100

Radiation therapy firm Varian Medical Systems has released its Eclipse 15.5...Read more on AuntMinnie.comRelated Reading: Varian holds clinical workshop at Algerian facility Varian appoints new VP Varian inks deal with Bionix Varian treats 1st patient with HyperArc Philips, Varian, IBA partner on Singapore cancer center (Source: AuntMinnie.com Headlines)



Tailored Treatment for Head-and-Neck Cancer Mystery

Fri, 15 Sep 2017 17:27:13 +0100

Treatment TermsHead and Neck Cancer Overview Rob Vaughn found a lump on his neck that turned out to be cancer that had spread from somewhere else in his body. The trouble was, doctors couldn ’t find the original site of the cancer. That made his treatment decisions difficult -- until two Duke specialists offered him options, including the option for watchful waiting instead of extensive treatment. Hero Image20170914_robvaughn_neckcancer_083_herocrop.jpg Preview Image Content Blocks Header A Search for the Source of Cancer ContentVaughn, a Charlotte, NC, father of two, was 47 and in good health when he felt the lump on his neck, just above his left collarbone.  It turned out to be a tumor in a lymph node. He had it removed, and the pathology report showed it was squamous cell car...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.




Varian holds clinical workshop at Algerian facility

Thu, 14 Sep 2017 16:42:06 +0100

Radiation therapy firm Varian Medical Systems held its first education workshop...Read more on AuntMinnie.comRelated Reading: Varian appoints new VP Varian inks deal with Bionix Varian treats 1st patient with HyperArc Philips, Varian, IBA partner on Singapore cancer center FDA clears Varian's Halcyon rad therapy system (Source: AuntMinnie.com Headlines)



Cancer drug stimulates tripolar mode of mitosis

Tue, 12 Sep 2017 04:00:00 +0100

(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) Taxanes inhibit cell division and make cancer cells sensitive to radiation therapy. A current study has investigated the underlying mechanisms of this action - and which biomarkers may be useful for predicting the success of therapy. The study, published in the journal Oncogene, was carried out within the framework of the Clinical Cooperation Group Personalized Radiotherapy in Head and Neck Cancer at Helmholtz Zentrum M ü nchen and Munich University Hospital. (Source: EurekAlert! - Biology)